Riskpilot← Back to searchSign inGet full accessAptol Pharma ApS
APSBankruptCVR 39308967Thad Jones Vej 6, st. thResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20181 employeesaptolpharma.com
Revenue 2024
DKK 2K
-99% vs 2023
EBITDA margin
-5248.7%
-137% vs 2023
Equity ratio
-290.3%
Financial strength
Net profit 2024
DKK -131K
-143% vs 2023
| Revenue | DKK 2K | -99% |
| EBITDA | DKK -128K | -137% |
| Net profit | DKK -131K | -143% |
| Total assets | DKK 48K | -70% |
| Equity | DKK -140K | -1451% |
| Employees | 1 | — |
Legal name
Aptol Pharma ApS
CVR number
39308967
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
5. februar 2018
Share capital
DKK 52.500
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at udvikle nye lægemidler alene eller i partnerskaber.
Address
Thad Jones Vej 6, st. th
Phone
+4526784520
Email
aptolpharm@gmail.com
Website
aptolpharma.com
- Event
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | -422 | 414 | 2 |
| Staff expenses | -0 | -148 | -304 | -0 | -0 | -73 | -131 |
| EBITDA | 89 | -249 | -441 | 0 | -422 | 342 | -128 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 89 | -249 | -441 | 0 | -422 | 342 | -128 |
| Net financials | 39 | 300 | -118 | 0 | 1 | -0 | -3 |
| Profit before tax | 129 | 300 | 6 | 0 | -421 | 342 | -131 |
| Tax | -0 | 53 | 9 | -0 | -87 | 34 | -0 |
| Net profit | 129 | -2 | -2 | 0 | -334 | 308 | -131 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | 75 | 50 | 50 | 50 | 104 | 163 | 48 |
| Equity | 50 | 50 | 50 | 50 | -317 | -9 | -140 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 25 | 0 | 0 | 0 | 421 | 172 | 189 |
| Total debt | 25 | 0 | 0 | 0 | 421 | 172 | 189 |
EBITDA margin
-5248.7%
This company
15.8%
Market median
-33320% vs market
20182024
Equity ratio
-290.3%
This company
38.2%
Market median
-860% vs market
20182024
Return on equity
-13128900.0%
This company
18.4%
Market median
-71352817% vs market
20182024
Net profit margin
-5376.3%
This company
8.1%
Market median
-66474% vs market
20182024
Asset turnover
0.05×
This company
1.12×
Market median
-96% vs market
20182024
Debt / equity
1.34×
This company
0.62×
Market median
-116% vs market
20182024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-02-05 – 2018-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
KG Founder | Founder | 2018 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2023 | — | — | |
| Chairman | 2025 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
KGAA Holding ApS | Company | 33.3% | 33.3% | 2025 |
| Individual | 15.0% | 15.0% | 2025 | |
| Individual | 15.0% | 15.0% | 2025 | |
| Individual | 10.0% | 10.0% | 2025 | |
ADT HOLDING ApS | Company | 10.0% | 10.0% | 2025 |
2200 HOLDING ApS | Company | 15.0% | 15.0% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Aptol Pharma ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kira Gerber Astakhova | Founder | 0 companies |
| Anders Dyhr Dombernowsky-Toft | Chairman | 0 companies |
| Mads Hartvig Clausen | Chairman | 0 companies |